DEAL ANNOUNCEMENT

McDermott Will & Schulte advises 1315 Capital on growth investment in Velentium Medical

Sep 25, 2026

Read time: 2 min

Global law firm McDermott Will & Schulte advised 1315 Capital, a Philadelphia-based, healthcare-focused private equity firm, in its growth capital investment in Velentium Medical, a medical technology innovation, development, and manufacturing company specializing in active Class II wearable and Class III implantable medical devices.

1315 Capital’s investment supports Velentium Medical’s continued expansion of commercial manufacturing operations, enhancement of its product development and regulatory capabilities, investment in automation and infrastructure, and pursuit of strategic growth opportunities across the medical device market.

The McDermott team was led by Bernie Grondin, with invaluable support from Morgan Pollard, Marissa Hill Daley, Kevin Hall, Justin Hier, Phoebe Hebson, Courtney Seams, Alejandra Chumbes, Jacob Hollinger, Paul Gadiock, and Amy Pimentel.